BioLight Life Sciences Ltd (BOLT) — Strategic Asset Allocation Index
BioLight Life Sciences Ltd (BOLT) has a Strategic Asset Allocation Index of 6.2% as of December 2022. Strategic assets (PP&E of ILA3.34 Million plus long-term investments of ILA-) total ILA3.34 Million, measured against net assets of ILA53.69 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see market cap of BioLight Life Sciences Ltd.
SAAI
Strategic Assets
PP&E
Net Assets
BioLight Life Sciences Ltd Strategic Asset Allocation Index (2006–2022)
This chart shows how BioLight Life Sciences Ltd's Strategic Asset Allocation Index has evolved across 15 annual periods from 2006 to 2022. As of December 2022, the index stands at 6.2%, representing strategic assets of ILA3.34 Million against net assets of ILA53.69 Million ILA. See BOLT net asset quality score to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for BioLight Life Sciences Ltd (2006–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for BioLight Life Sciences Ltd from 2006 to 2022, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore BOLT net asset momentum to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (ILA) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 6.2% | ILA3.34 Million | ILA3.34 Million | ILA- | ILA53.69 Million | ▲ +0.9 pp |
| 2021 | 5.3% | ILA3.26 Million | ILA3.26 Million | ILA- | ILA61.42 Million | ▲ +0.0 pp |
| 2020 | 5.3% | ILA3.16 Million | ILA3.16 Million | ILA- | ILA60.11 Million | ▲ +4.2 pp |
| 2019 | 1.0% | ILA714.00K | ILA714.00K | ILA- | ILA68.15 Million | ▼ -25.1 pp |
| 2018 | 26.1% | ILA20.31 Million | ILA304.00K | ILA20.01 Million | ILA77.80 Million | ▲ +14.6 pp |
| 2017 | 11.5% | ILA922.00K | ILA922.00K | ILA- | ILA8.03 Million | ▲ +3.6 pp |
| 2016 | 7.8% | ILA1.29 Million | ILA1.29 Million | ILA- | ILA16.41 Million | ▲ +6.1 pp |
| 2015 | 1.7% | ILA822.00K | ILA743.00K | ILA79.00K | ILA47.06 Million | ▼ -1.4 pp |
| 2014 | 3.2% | ILA819.00K | ILA819.00K | ILA- | ILA25.74 Million | ▼ -0.9 pp |
| 2013 | 4.1% | ILA911.00K | ILA911.00K | ILA- | ILA22.11 Million | ▲ +1.6 pp |
| 2012 | 2.5% | ILA947.00K | ILA947.00K | ILA- | ILA37.34 Million | ▼ -4.5 pp |
| 2011 | 7.1% | ILA1.66 Million | ILA1.66 Million | ILA- | ILA23.55 Million | ▼ -58.7 pp |
| 2010 | 65.8% | ILA1.79 Million | ILA1.79 Million | ILA- | ILA2.72 Million | ▲ +57.5 pp |
| 2009 | 8.2% | ILA1.09 Million | ILA1.09 Million | ILA- | ILA13.31 Million | ▲ +6.0 pp |
| 2006 | 2.2% | ILA176.00K | ILA176.00K | ILA- | ILA8.01 Million | — |